Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Dementia risk high after ICH

A large study shows that nearly a third of patients who survive an intracerebral haemorrhage will go on to develop dementia within 4 years.

11 May 2016

Modified dosage of clot-busting drug can reduce intracerebral haemorrhage

The safety of a controversial clot-busting drug has been investigated by researchers, who have shown a modified dosage can reduce serious bleeding in the brain and improve survival rates.

11 May 2016

ENCHANTED results challenge reduced alteplase dose in Asian stroke patients

A reduced dose of alteplase has failed to prove itself noninferior to the standard dose in a predominantly Asian population of patients with ischaemic stroke.

11 May 2016

Depression course predicts dementia risk

Patients with late-life depression have an increased risk of dementia if their symptoms increase over time, whereas a single episode of depression, even if severe, does not carry a significant risk, study findings indicate.

10 May 2016

Potential new intraocular treatment based on RAS manipulation can prevent or reverse diabetic retinopathy

Pathologic changes of the retina caused by diabetes is the leading cause of blindness in working adults. Diabetic retinopathy has no known cure, treatment options are inadequate, and prevention strategies offer limited protection. In the first of its kind, a report in The American Journal of Pathology describes a potential new intraocular treatment based on manipulating the renin angiotensin system (RAS) that both prevents and reverses some characteristics of diabetic retinopathy in a mouse model.

10 May 2016

UCLA neurologist highlights steps that can help Americans reduce stroke risk

Getting more exercise, giving up cigarettes and monitoring cholesterol and blood pressure are a few steps Americans can take to reduce their risk of stroke, says Doojin Kim, MD, a neurologist at UCLA Medical Center, Santa Monica who often treats patients who have suffered a stroke, the No. 4 cause of death and the No. 1 cause of adult disability in the U.S.

10 May 2016

CoSTREAM project aims to find common mechanisms, pathways in stroke and Alzheimer's disease

Stroke and Alzheimer's disease are major diseases imposing a huge burden on aging societies. It has long been recognized that stroke and Alzheimer's disease often co-occur, and it has been speculated that the two disorders have an overlapping pathogenesis.

10 May 2016

Survey finds variability among physicians when treating stroke patients

A physician has to make many quick decisions when confronted with a stroke patient. Should treatment be intensive or comfort-based, or somewhere in between?

9 May 2016

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Women younger than 55 years of age who undergo percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) are more likely to experience one-year adverse cardiovascular events due to risk factors such as diabetes and chronic kidney disease, yet they are less likely to receive potent antiplatelet therapy than men. The PROMETHEUS study found that outcomes for both men and women post-PCI are dependent on their baseline risk factors, not their sex.

9 May 2016

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

A new study finds the use of moderate sedation, in which patients do not need a breathing tube, leads to better clinical outcomes as compared to general anesthesia for patients undergoing transcatheter aortic valve replacement (TAVR).

9 May 2016

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement. It also controls the accumulation of excess levels of iron in beta-thalassemia that often causes severe toxic effects.

9 May 2016

Novel anticoagulants on ‘as-needed basis’ could be safe alternative to lowering stroke risk

Patients with atrial fibrillation (AF), a rapid irregular heartbeat caused by pooling blood in the heart which can lead to heart failure and stroke, are often treated with an ablation, a minimally invasive procedure used to remove the tissue which causes the pooled blood.

9 May 2016

New book highlights importance of hyperacute care for intracerebral hemorrhage

The age-standardized mortality rate for hemorrhagic stroke has decreased worldwide over the past two decades, but incidence, number of deaths, and lost disability-adjusted life-years continue to increase. While hemorrhagic stroke occurs half as frequently globally as ischemic stroke, it causes significantly more deaths and lost DALY.

9 May 2016

Wolff-Parkinson-White patients continue to have atrial fibrillation risk even after catheter ablation, study finds

Patients with Wolff-Parkinson-White syndrome who receive catheter ablation to cure their abnormal heart rhythms are just as likely as non-ablated patients to develop atrial fibrillation no matter what age they receive ablation, according to a new study.

6 May 2016

Drinking tart Montmorency cherry juice can reduce early signs of hypertension

Drinking tart Montmorency cherry juice significantly reduces high blood pressure at a level comparable to that achieved by medication, according to new research from Northumbria University, Newcastle.

6 May 2016

SFU scientists aim to develop new control system for most advanced bionic hands

A Canadian athlete's dream to one day "move" his fingers again after losing an arm in a workplace accident is now within grasp, thanks to a robotic arm prosthesis being developed at Simon Fraser University.

5 May 2016

Long-term Warfarin use may increase dementia rates in AF patients

A new study of more than 10,000 patients treated long term with the blood thinner, Warfarin, reveals higher rates of dementia for patients with atrial fibrillation versus non-AF patients

5 May 2016

Study shows short-term statin treatment does not benefit heart surgery patients

Giving daily doses of statins for a few days before and after heart surgery does not prevent heart muscle damage or the development of atrial fibrillation (AF), according to an international clinical trial led by the University of Oxford and funded by the British Heart Foundation.

5 May 2016

Proton therapy offers new hope to patients with inoperable tumors

An enormous high tech machine is providing new hope to patients across the country with inoperable tumors. Proton therapy is a precise radiation technique that reduces the side effects often accompanied by traditional treatment options. Thanks to this remarkable technology, a new proton therapy center at UF Health Cancer Center - Orlando Health is saving the eyesight of a new mother who was diagnosed with a tumor behind her eye during her second trimester of pregnancy.

5 May 2016

Stroke Awareness Month: Meridian Neuroscience provides latest information about stroke prevention, treatments

In observance of Stroke Awareness Month, Meridian Neuroscience is kicking off a series of informative community events, providing expert advice, tips, and the latest information about stroke prevention and treatments. The events will take place at Meridian Health locations throughout Monmouth and Ocean counties.

4 May 2016

Stroke News and Research

Further Reading

Dementia risk high after ICH

Modified dosage of clot-busting drug can reduce intracerebral haemorrhage

ENCHANTED results challenge reduced alteplase dose in Asian stroke patients

Depression course predicts dementia risk

Potential new intraocular treatment based on RAS manipulation can prevent or reverse diabetic retinopathy

UCLA neurologist highlights steps that can help Americans reduce stroke risk

CoSTREAM project aims to find common mechanisms, pathways in stroke and Alzheimer's disease

Survey finds variability among physicians when treating stroke patients

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Moderate sedation leads to better clinical outcomes than general anesthesia for TAVR patients

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Novel anticoagulants on ‘as-needed basis’ could be safe alternative to lowering stroke risk

New book highlights importance of hyperacute care for intracerebral hemorrhage

Wolff-Parkinson-White patients continue to have atrial fibrillation risk even after catheter ablation, study finds

Drinking tart Montmorency cherry juice can reduce early signs of hypertension

SFU scientists aim to develop new control system for most advanced bionic hands

Long-term Warfarin use may increase dementia rates in AF patients

Study shows short-term statin treatment does not benefit heart surgery patients

Proton therapy offers new hope to patients with inoperable tumors

Stroke Awareness Month: Meridian Neuroscience provides latest information about stroke prevention, treatments

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News